NCT07196839View on ClinicalTrials.gov

Determining the Association of TTR Stabilizing Therapy With Circulating TTR Amyloid Aggregates Over Time in Patients With ATTR-CM: Longitudinal Biomarker Study

Not yet recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

March 31, 2027

Conditions

Transthyretin (TTR) Amyloid Cardiomyopathy

Trial Locations (1)

75248

UT Southwestern Medical Center, Dallas

All Listed Sponsors

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Texas Southwestern Medical Center

OTHER

NCT07196839 - Determining the Association of TTR Stabilizing Therapy With Circulating TTR Amyloid Aggregates Over Time in Patients With ATTR-CM: Longitudinal Biomarker Study | Biotech Hunter | Biotech Hunter